Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge ; volume:12 ; number:1 ; day:21 ; month:11 ; year:2016 ; pages:1-6 ; date:12.2016
BMC veterinary research ; 12, Heft 1 (21.11.2016), 1-6, 12.2016
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/s12917-016-0888-0
- URN
-
urn:nbn:de:1111-201612118115
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sattler, Tatjana
- Pikalo, Jutta
- Wodak, Eveline
- Schmoll, Friedrich
- SpringerLink (Online service)
Ähnliche Objekte (12)
Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge : Ability of ELISAs to detect antibodies against porcine respiratory andreproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge
Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches
Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches
An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration
Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs
Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs
Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice
Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs
Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs
Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs
Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains
The interaction of porcine respiratory pathogens with airway epithelial cells of pigs
Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge : Ability of ELISAs to detect antibodies against porcine respiratory andreproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge
Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches
Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches
An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration
Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs
Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs
Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice
Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs
Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs
Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs
Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains
The interaction of porcine respiratory pathogens with airway epithelial cells of pigs
Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge : Ability of ELISAs to detect antibodies against porcine respiratory andreproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge
Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches
Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches
An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration
Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs
Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs
Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice
Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs
Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs
Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs
Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains